Avid Bioservices, Inc.
2642 Michelle Drive, Suite 200
Tustin
California
92780
United States
Tel: 714-508-6100
Fax: 714-439-1300
Website: http://www.avidbio.com/
About Avid Bioservices, Inc.
Avid Bioservices Inc., located in Tustin CA, is a dedicated contract development and manufacturing organization (“CDMO”) focused on development and CGMP manufacturing of biopharmaceuticals products derived from mammalian cell culture. Avid provides a comprehensive range of process development, high quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With over 28 years of experience producing monoclonal antibodies, enzymes, and recombinant proteins in batch, fed-batch, and perfusion modes, Avid's services include CGMP clinical and commercial product manufacturing, purification, release and stability testing as well as regulatory strategy, submission and support. Avid also provides a variety of process development activities, including cell culture and feed optimization, analytical methods development, and product characterization.
Stock Symbol: CDMO
Take a virtual 3D tour of our Myford North facility featuring our CGMP single-use drug substance manufacturing suite and quality control labs.
140 articles about Avid Bioservices, Inc.
-
Avid Bioservices, Inc. Receives Mutliple 2017 CMO Leadership Awards For Quality, Reliability, Capabilties, Expertise And Compatibility
3/24/2017
-
Avid Bioservices, Inc. To Participate In Avid Bioservices, Inc.'s 8th Annual The Bioprocessing Summit
8/9/2016
-
Avid Bioservices, Inc. To Exhibit At The 2016 BIO International Convention
6/2/2016
-
Avid Bioservices, Inc. Appoints Pete Gagnon As Vice President Of Process Sciences
5/23/2016
-
BIO2015: Avid Bioservices, Inc. To Highlight The Upcoming Launch Of Its New State-Of-The-Art-Facility At The BIO International Convention
6/19/2015
-
Avid Bioservices, Inc. To Make Three Presentations At IBC's Biopharmaceutical Development And Production Week Conference Highlighting Its Innovative Applications For Developing Purification Methods And Quantitative Analytical Assays To Achieve And Monitor
4/3/2015
-
Avid Bioservices, Inc. Receives CMO Leadership Awards For Its Commitment To Innovation And Reliability
3/25/2015
-
Avid Bioservices, Inc. Announces Expansion Of cGMP Manufacturing Capacity
12/12/2014
-
Avid Bioservices, Inc. To Highlight Novel Methods For Increasing Protein Expression And Developing An Optimized Upstream Process At IBC's Biopharmaceutical Development & Production Week Conference
3/25/2014
-
Avid Bioservices, Inc. Highlights Cell Culture Development Expertise At The Well Characterized Biotechnology Pharmaceutical 18th Symposium
1/27/2014
-
Avid Bioservices, Inc. to Present Two Successful Case Studies Highlighting Development and Manufacturing Expertise That Supports Commercial Production at Upcoming Industry Events
9/12/2013
-
Avid Bioservices, Inc. Highlights New Bioassay Capabilities to Support Phase III and Commercial-Stage Development Programs
5/14/2013
-
Avid Bioservices, Inc. to Present a Case Study on cGMP Production Scale-Up, Optimization and Transition From a Stainless Steel to a Fully Disposable Process at Biotechnology Industry Organization (BIO) International Convention
4/22/2013
-
Avid Bioservices, Inc. Announces Completion of Facility Upgrades in Response to Increased Demand for Its Contract Manufacturing Services
12/13/2012
-
Advanced BioScience Laboratories, Inc. Awards Avid Bioservices, Inc. HIV Vaccine Development and Manufacturing Contract
9/27/2012
-
Avid Bioservices, Inc. Announces Addition of Novel Bacteriophage Production System at Upcoming Biotechnology Industry Organization (BIO) Conference as Part of a Collaboration With Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.)
6/12/2012
-
Avid Bioservices, Inc. Highlights Antibody Engineering, Expression and Bioassay Expertise at American Association for Cancer Research
4/3/2012
-
Avid Bioservices, Inc. to Present at IBC's Antibody Development and Production Conference
2/24/2012
-
Avid Bioservices, Inc. to Present Comparability Studies of Large-Scale Manufacturing of Clinical-Stage Antibody
3/9/2011
-
Avid Bioservices, Inc. Secures New Biosimilar Development Project
12/8/2010